Therapeutic use of VEGF-C and CCBE1

Forskningsoutput: Patent

Sammanfattning

The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.
Originalspråkengelska
Utgivningsår19 feb 2015
StatusPublicerad - 19 feb 2015
MoE-publikationstypH1 Beviljat patent

Vetenskapsgrenar

  • 3111 Biomedicinska vetenskaper

Citera det här